FI20011664L - Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö - Google Patents
Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö Download PDFInfo
- Publication number
- FI20011664L FI20011664L FI20011664A FI20011664A FI20011664L FI 20011664 L FI20011664 L FI 20011664L FI 20011664 A FI20011664 A FI 20011664A FI 20011664 A FI20011664 A FI 20011664A FI 20011664 L FI20011664 L FI 20011664L
- Authority
- FI
- Finland
- Prior art keywords
- cancer
- oligosaccharide sequences
- specific oligosaccharide
- specific
- sequences
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 150000002482 oligosaccharides Polymers 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20011664A FI20011664L (fi) | 2001-08-17 | 2001-08-17 | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö |
| PCT/FI2002/000674 WO2003016464A2 (en) | 2001-08-17 | 2002-08-16 | Cancer specific oligosaccharide sequences and use thereof |
| EP02748913A EP1417214A2 (en) | 2001-08-17 | 2002-08-16 | Cancer specific oligosaccharide sequences and use thereof |
| US10/486,714 US8313912B2 (en) | 2001-08-17 | 2002-08-16 | Cancer specific oligosaccharide sequences and use thereof |
| JP2003521773A JP2005500057A (ja) | 2001-08-17 | 2002-08-16 | 癌特異的オリゴ糖配列およびその用途 |
| AU2002319338A AU2002319338A1 (en) | 2001-08-17 | 2002-08-16 | Cancer specific oligosaccharide sequences and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20011664A FI20011664L (fi) | 2001-08-17 | 2001-08-17 | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI20011664A0 FI20011664A0 (fi) | 2001-08-17 |
| FI20011664L true FI20011664L (fi) | 2003-02-18 |
Family
ID=8561754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20011664A FI20011664L (fi) | 2001-08-17 | 2001-08-17 | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8313912B2 (fi) |
| EP (1) | EP1417214A2 (fi) |
| JP (1) | JP2005500057A (fi) |
| AU (1) | AU2002319338A1 (fi) |
| FI (1) | FI20011664L (fi) |
| WO (1) | WO2003016464A2 (fi) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20011671L (fi) * | 2001-08-20 | 2003-02-21 | Carbion Oy | Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö |
| AU2002950878A0 (en) * | 2002-08-20 | 2002-09-12 | Proteome Systems Intellectual Property Pty Ltd | Method for diagnosing disorders |
| WO2005111627A2 (en) * | 2004-04-15 | 2005-11-24 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
| US20060127950A1 (en) * | 2004-04-15 | 2006-06-15 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
| US7651847B2 (en) * | 2004-06-22 | 2010-01-26 | The Regents Of The University Of California | Methods of oligosaccharide profiling for the detection of cancer |
| US8039208B2 (en) | 2005-04-26 | 2011-10-18 | National Institute For Bioprocessing Research And Training Limited (Nibrt) | Automated strategy for identifying physiological glycosylation markers(s) |
| US20060269979A1 (en) * | 2005-04-26 | 2006-11-30 | Dwek Raymond A | High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases |
| US7892752B2 (en) | 2005-04-26 | 2011-02-22 | Dwek Raymond A | Glycosylation markers for cancer diagnosing and monitoring |
| EP1883821B1 (en) * | 2005-04-26 | 2009-11-04 | National Institute for Bioprocessing Research and Training Limited | Automated glycofingerprinting strategy |
| WO2006114659A1 (en) | 2005-04-26 | 2006-11-02 | Dwek Raymond A | Glycosylation markers for cancer diagnosing and monitoring |
| FI20055398A0 (fi) | 2005-07-08 | 2005-07-08 | Suomen Punainen Risti Veripalv | Menetelmä solupopulaatioiden evaluoimiseksi |
| CA2652232A1 (en) | 2005-07-11 | 2007-01-18 | Suomen Punainen Risti, Veripalvelu | Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof |
| FI20055417A0 (fi) * | 2005-07-20 | 2005-07-20 | Glykos Finland Oy | Syöpäpesifiset glykaanit ja niiden käyttö |
| US7981625B2 (en) | 2008-04-15 | 2011-07-19 | The Board Of Trustees Of The Leland Stanford Junior University | Prostate cancer glycan markers and autoantibody signatures |
| EP2166085A1 (en) | 2008-07-16 | 2010-03-24 | Suomen Punainen Risti Veripalvelu | Divalent modified cells |
| WO2010064683A1 (ja) | 2008-12-03 | 2010-06-10 | 財団法人野口研究所 | 前立腺癌の判定方法 |
| JP5443156B2 (ja) * | 2009-12-28 | 2014-03-19 | 公益財団法人野口研究所 | 前立腺癌を判定する方法 |
| GB201705686D0 (en) | 2017-04-07 | 2017-05-24 | Centauri Therapeutics Ltd | Novel compounds and therapeutic uses thereof |
| WO2020013097A1 (ja) * | 2018-07-11 | 2020-01-16 | 公益財団法人がん研究会 | 前立腺がんに特異的な糖鎖、及びこれを用いた検査方法 |
| BR112021008712A2 (pt) * | 2018-11-08 | 2021-08-10 | Dsm Ip Assets B.V. | métodos de modulação de metabólitos gastrointestinais |
| MX2021005367A (es) * | 2018-11-08 | 2021-09-14 | Dsm Ip Assets Bv | Metodos para modular selectivamente el crecimiento microbiano gastrointestinal. |
| CN112129938B (zh) * | 2019-06-25 | 2023-08-18 | 中国科学院分子细胞科学卓越创新中心 | UDP-Glc在肺癌转移评估中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4455380A (en) * | 1982-01-29 | 1984-06-19 | Otsuka Pharmaceutical Co., Ltd. | Process for determining tumor-associated glycolinkage |
| US4904596A (en) | 1985-08-07 | 1990-02-27 | Fred Hutchinson Cancer Research Center | Hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside |
| US5660834A (en) | 1988-03-11 | 1997-08-26 | The Biomembrane Institute | Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates |
| WO1993017033A1 (en) * | 1992-02-19 | 1993-09-02 | The Biomembrane Institute | Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| NZ247105A (en) * | 1992-03-12 | 1994-11-25 | Lilly Co Eli | Carbohydrate structures produced by human kidney 293 cells and pharmaceutical compositions |
| AU1444697A (en) * | 1996-01-30 | 1997-08-22 | Novartis Ag | Sialyl-lewisa and sialyl-lewisx epitope analogues |
| US5972907A (en) * | 1997-10-31 | 1999-10-26 | Health Research, Inc. | Synthetic core 2-like branched structures containing GalNAc-lewisx and Neu5Acα2-3Galβ1-3GalNAc sequences as novel ligands for selectins |
| WO2000017654A1 (en) * | 1998-09-21 | 2000-03-30 | Cummings Richard D | Assays for helminth infections |
| WO2002077649A1 (fr) * | 2001-03-27 | 2002-10-03 | Teikoku Hormone Mfg. Co., Ltd. | Procede de diagnostic de cancer du sein |
| WO2005005601A2 (en) * | 2003-06-09 | 2005-01-20 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
-
2001
- 2001-08-17 FI FI20011664A patent/FI20011664L/fi not_active IP Right Cessation
-
2002
- 2002-08-16 AU AU2002319338A patent/AU2002319338A1/en not_active Abandoned
- 2002-08-16 JP JP2003521773A patent/JP2005500057A/ja active Pending
- 2002-08-16 EP EP02748913A patent/EP1417214A2/en not_active Withdrawn
- 2002-08-16 WO PCT/FI2002/000674 patent/WO2003016464A2/en active Application Filing
- 2002-08-16 US US10/486,714 patent/US8313912B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005500057A (ja) | 2005-01-06 |
| US8313912B2 (en) | 2012-11-20 |
| WO2003016464A2 (en) | 2003-02-27 |
| EP1417214A2 (en) | 2004-05-12 |
| FI20011664A0 (fi) | 2001-08-17 |
| AU2002319338A1 (en) | 2003-03-03 |
| US20040253651A1 (en) | 2004-12-16 |
| WO2003016464A3 (en) | 2003-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI20011664A0 (fi) | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö | |
| FI20011671A0 (fi) | Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö | |
| DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
| DK3266791T3 (da) | Mærkede nukleotider | |
| IS6934A (is) | Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar | |
| DE50208638D1 (de) | Katheter | |
| NO20034159L (no) | Östrogen-gestagen-kombinasjonspreparat og anvendelse derav | |
| EE200300311A (et) | Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim | |
| DE50106015D1 (de) | Osteosynthesemittel | |
| DE60225985D1 (de) | Dentaleinheit | |
| DE60223576D1 (de) | Hautbehandlungszusammensetzung | |
| DE50209245D1 (de) | Neuroprotektives medikament | |
| DE60114244D1 (de) | Osteosynthesevorrichtung | |
| ATE299873T1 (de) | Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate | |
| DE60220799D1 (de) | Hypoglykämisches mittel | |
| DE10107471B4 (de) | Vitrine | |
| DE60136966D1 (de) | Pflanzenstärkendes mittel | |
| DE60219418T8 (de) | Silanylphenole und -naphthole | |
| DE50110467D1 (de) | Staffelei | |
| FI20012608A0 (fi) | Diagnostiset menetelmät | |
| DE60123297D1 (de) | Leistungsstarkes mikrofilter und teilergerät | |
| DE60228736D1 (de) | Menschliches bmcc1-gen | |
| DK1427748T3 (da) | 17alfa-hydroxy-14beta-steroider med hormonal virkning | |
| DE60206034D1 (de) | Spritze | |
| DE60204435D1 (de) | Spritze |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired |